港大醫學院開發全球首個甲狀腺癌診斷人工智能模型 準確率超九成 診前準備時間減半

HKUMed develops world’s first AI model for thyroid cancer diagnosis, with over 90% accuracy and reduced consultation preparation time

香港大學李嘉誠醫學院獲捐贈亞洲首部國際級創新儀器--突破性組織碎化技術 高效益、無創、無痛肝癌最新療法

Donation of Asia's first world-class medical device to the HKU Li Ka Shing Faculty of Medicine--Histotripsy technology: a non-invasive, painless, highly efficient surgery for liver cancer

港大醫學院全球首個「肝立方」獲日內瓦發明展金獎 為肝癌病人提供最佳治療方案

HKUMed's world-first ‘Liver-in-Cube’ wins a Gold medal at International Exhibition of Inventions of Geneva, advancing precise cancer treatment

港大醫學院研究發現缺血性中風患者 發病逾六小時後接受取栓手術治療仍有效 逾三成患者獲良好臨床效果

HKUMed study finds good clinical outcomes for over 30% of ischaemic stroke patients receiving endovascular treatment beyond six hours from onset

港大醫學院首創「先縮後除」配以活肝移植 根治末期肝癌成全球先例

HKUMed sets global precedent: Successfully cures terminal liver cancer through combined 'Reduce and Remove' strategy with living donor liver transplantation

港大團隊研發嶄新「虛擬病人」問診應用程式 醫科訓練打破時間地域限制 促進國際醫學教育交流

HKU develops novel 'AI virtual patients' diagnostic application

Breaking spatial and geographical barriers for medical training

Revolutionising global medical education exchanges

醫學院發現手術出院後使用鴉片類藥物 會增加患者再次入院及死亡風險

HKUMed finds higher risks of hospital readmission and mortality among surgical patients who were discharged with opioids

港大醫學院與國際學者攜手 建立使用血漿 EB 病毒 DNA 於鼻咽癌診斷及治療的共識

HKUMed establishes international consensus recommendations on using plasma EBV DNA in clinical management of nasopharyngeal carcinoma

港大醫學院全球首創嶄新中期肝癌「先縮後除」綜合治療方案

HKUMed discovered a new treatment strategy for locally advanced liver cancer by ‘Reduce and Remove’ – a novel tri-modality therapy

港大醫學院全球首次發現肝癌免疫治療的新靶點

HKUMed discovers a novel immunotherapeutic target against hepatocellular carcinoma first time in the world

Many congratulations to Dr. Vincent Lui and Professor Paul Tam for the success of their 11^th round RGC Theme-Based Research Scheme application!

港大醫學院發現常見於香港華人但罕被記載而與藥物有關的基因變異
揭示個人化醫療潛力

HKUMed identifies rarely documented pharmacogenetic variants commonly found among Hong Kong Chinese, highlighting the potential for personalised medicine

港大醫學院發現β-澱粉樣蛋白異常沉積是膽道閉塞的新發病機制

HKUMed discovered beta-amyloid deposition to be a novel disease mechanism for Biliary Atresiaz

港大醫學院引入並完成亞洲首宗水蒸氣熱力治療手術以治療良性前列腺增生症

HKUMed introduced and carried out Asia’s first Water Vapour Thermal Therapy for Benign Prostatic Hyperplasia

港大醫學院揭示感染新型冠狀病毒兒童的臨床特徵和流行病學趨勢

HKUMed researchers reveal the clinical characteristics and epidemiological trend of COVID-19 infected children